TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma

por Li, Xiang, Cheng, Ruochuan
Publicado 2023

The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?

por Liu, Wen, Yan, Xuejing, Cheng, Ruochuan
Publicado 2022

Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study

por Li, Xiang, Zhang, Hanwen, Zhou, Yu, Cheng, Ruochuan
Publicado 2021

Surgical treatment of pediatric and adolescent papillary thyroid cancer: a retrospective study of 54 patients in a single center

por Su, Yanjun, Cheng, Shaohao, Diao, Chang, Ma, Yunhai, Qian, Jun, Cheng, Ruochuan
Publicado 2022

Single inferior parathyroid autotransplantation during total thyroidectomy with bilateral central lymph node dissection for papillary thyroid carcinoma: a retrospective cohort stud...

por Dong, Zhizhong, Liu, Wen, Peng, Ying, Zhan, Xiangxiang, Su, Yanjun, Diao, Chang, Cheng, Ruochuan
Publicado 2023

Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases

por Liu, Wen, Cheng, Ruochuan, Su, Yanjun, Diao, Chang, Qian, Jun, Zhang, Jianming, Ma, Yunhai, Fan, Yinxia
Publicado 2017

The impact of the initial operation of PTC in children on recurrence: 9-year experience in a single center

por Cheng, Shaohao, Cheng, Ruochuan, Zhao, Shunshun, Zhang, Min, Diao, Chang, Ma, Yunhai, Qian, Jun, Su, Yanjun
Publicado 2022

Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma

por Liu, Wen, Cheng, Ruochuan, Ma, Yunhai, Wang, Dan, Su, Yanjun, Diao, Chang, Zhang, Jianming, Qian, Jun, Liu, Jin
Publicado 2018

Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAF(V600E) Mutations

por Su, Yanjun, Cheng, Shaohao, Qian, Jun, Zhang, Min, Li, Tuanli, Zhang, Ying, Diao, Chang, Zhang, Ling, Cheng, Ruochuan
Publicado 2021

A Mathematical Model to Assess the Effect of Residual Positive Lymph Nodes on the Survival of Patients With Papillary Thyroid Microcarcinoma

por Liu, Wen, Yan, Xuejing, Dong, Zhizhong, Su, Yanjun, Ma, Yunhai, Zhang, Jianming, Diao, Chang, Qian, Jun, Ran, Tao, Cheng, Ruochuan
Publicado 2022

Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools

por Pan, Xiaoyu, Chen, Jiechun, Wang, Weijie, Chen, Ling, Wang, Lin, Ma, Quan, Zhang, Jianbo, Chen, Lichao, Wang, Gang, Zhang, Meixi, Wu, Hao, Cheng, Ruochuan
Publicado 2016

The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling

por Wang, Gang, Chen, Ling, Pan, Xiaoyu, Chen, Jiechun, Wang, Liqun, Wang, Weijie, Cheng, Ruochuan, Wu, Fan, Feng, Xiaoqing, Yu, Yingcong, Zhang, Han-Ting, O'Donnell, James M., Xu, Ying
Publicado 2016

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial

por Chi, Yihebali, Zheng, Xiangqian, Zhang, Yuan, Shi, Feng, Cheng, Ying, Guo, Zhuming, Ge, Minghua, Qin, Jianwu, Zhang, Jiewu, Li, Zhendong, Zhou, Xiaohong, Huang, Rui, Chen, Xiaohong, Liu, Hui, Cheng, Ruochuan, Xu, Zhengang, Li, Dapeng, Tang, Pingzhang, Gao, Ming
Publicado 2023

Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study

por Zhao, Jingzhu, Chi, Yihebali, Hu, Chuanxiang, Chen, Xiaohong, Ge, Minghua, Zhang, Yuan, Guo, Zhuming, Wang, Jun, Chen, Jie, Zhang, Jiewu, Cheng, Ying, Li, Zhendong, Liu, Hui, Qin, Jianwu, Zhu, Jingqiang, Cheng, Ruochuan, Xu, Zhengang, Li, Dapeng, Tang, Pingzhang, Gao, Ming, Zheng, Xiangqian
Publicado 2022

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma

por Gao, Ming, Ge, Minghua, Ji, Qinghai, Cheng, Ruochuan, Lu, Hankui, Guan, Haixia, Gao, Li, Guo, Zhuming, Huang, Tao, Huang, Xiaoming, Li, Xiaoming, Lin, Yansong, Liu, Qinjiang, Ni, Xin, Pan, Yi, Qin, Jianwu, Shan, Zhongyan, Sun, Hui, Wang, Xudong, Xu, Zhengang, Yu, Yang, Zhao, Daiwei, Zhang, Naisong, Zhang, Sheng, Zheng, Ying, Zhu, Jingqiang, Li, Dapeng, Zheng, Xiangqian, Chinese Association of Thyroid Oncology, (CATO), Chinese Anti-Cancer Association
Publicado 2017

2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer

por Gao, Ming, Ge, Minghua, Ji, Qinghai, Cheng, Ruochuan, Lu, Hankui, Guan, Haixia, Cui, Wei, Gao, Li, Gao, Zairong, Guo, Lin, Guo, Zhuming, Huang, Tao, Huang, Xiaoming, Lin, Yansong, Liu, Qinjiang, Ni, Xin, Qin, Jianwu, Ren, Li, Shan, Zhongyan, Sun, Hui, Wang, Xudong, Xu, Zhengang, Yu, Yang, Zhang, Bin, Zhao, Daiwei, Zheng, Ying, Zhu, Jingqiang, Zheng, Xiangqian, Chinese Association of Thyroid Oncology (CATO), China Anti-Cancer Association
Publicado 2018